Grown Rogue International (GRUSF) Interest Expenses (2011 - 2026)
Grown Rogue International (GRUSF) posted quarterly Interest Expenses of $768885.0 for Q1 2026, up 749.09% year-over-year from $90554.1 in Q1 2025, and down 100.0% quarter-over-quarter from $400.9 billion in Q4 2025.
Grown Rogue International (GRUSF) Interest Expenses (2011 - 2026) Analysis & Trends
Grown Rogue International's Interest Expenses history runs 15 years deep, the most recent figure standing at $768885.0 for Q1 2026.
- In Q1 2026, Interest Expenses rose 749.09% year-over-year to $768885.0; the TTM figure through Mar 2026 stood at $768885.0 (up 100.0% YoY), while the FY2025 annual figure was $1.8 million, down 59.46% from the prior year.
- Interest Expenses for Q1 2026 stood at $768885.0, down from $400.9 billion in the prior quarter.
- The five-year high for Interest Expenses was $400.9 billion in Q4 2025, with the low at -$125.2 billion in Q3 2025.
- The 5-year median for Interest Expenses is -$114660.0 (2022), against an average of $13.4 billion.
- The sharpest annual moves came in 2022 and 2026: Interest Expenses plunged 1444.67% in 2022, then soared 749.09% in 2026.
- Grown Rogue International's Interest Expenses stood at -$114660.0 in 2022, then slumped by 136.45% to -$271112.0 in 2023, then plunged by 37527563.84% to -$101.7 billion in 2024, then surged by 494.07% to $400.9 billion in 2025, then plunged by 100.0% to $768885.0 in 2026.
- Business Quant data shows GRUSF's Interest Expenses at $768885.0 in Q1 2026, $400.9 billion in Q4 2025, and -$125.2 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Grown Rogue International | 114.97 Mn | 109.89 Mn | 5.37 Mn | 1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.63 Mn |
| Jun 30, 2026 | 27.63 Mn |
| Mar 31, 2026 | 768,885.00 |
| Mar 31, 2026 | 768,885.00 |
| Dec 31, 2025 | 400.94 Bn |
| Dec 31, 2025 | 400.94 Bn |
| Sep 30, 2025 | -125.20 Bn |
| Sep 30, 2025 | -125.20 Bn |
| Jun 30, 2025 | -157,283.00 |
| Jun 30, 2025 | -157,283.00 |
| Mar 31, 2025 | -118,456.00 |
| Mar 31, 2025 | -118,456.00 |
| Sep 30, 2024 | -101.74 Bn |
| Sep 30, 2024 | -101.74 Bn |
| Jun 30, 2024 | -58,225.11 |
| Jun 30, 2024 | -58,225.11 |
| Mar 31, 2024 | -89,687.00 |
| Mar 31, 2024 | -89,687.00 |
| Oct 31, 2023 | -271,112.00 |
| Oct 31, 2023 | -271,112.00 |